Gentle Clearing 73 is an independent resource on ibogaine-related brain research and safety. Hearth Synapse helps people interpret emerging evidence on ibogaine-associated neuroplasticity, brain-structure findings, and safety concerns, and distinguishes preliminary observations from established clinical conclusions.
We focus on transparent methods: how evidence is collected, which outcome measures are reported, and what limitations affect interpretation. That editorial approach draws on registries, peer-reviewed literature, and authoritative guidance to contextualize findings for readers.
We maintain tracked registries of new publications and preprints and note changes across versions.
Each study is reviewed for sample size, controls, imaging methods, and statistical transparency.
Summaries separate robust findings from exploratory observations and flag reproducibility concerns.
Annotations highlight design choices and potential biases so readers can follow the evidence path.
For a sense of the research landscape that motivates this work, we reference clinical registries and broadly used reporting standards such as CONSORT on trial reporting (CONSORT overview (Wikipedia)) and methodological summaries hosted by academic centers like the U.S. National Institutes of Health, which inform how we evaluate study quality.
We curate evidence from primary sources: indexed journal articles, registered clinical trials, and regulatory advisories. Our vetting emphasizes reproducibility indicators (pre-registration, code/data availability) and methodological clarity. Where appropriate, we cross-check clinical details with authoritative public resources such as major university research pages (Harvard University) to ensure interpretive context.
We also link readers to operational information when relevant. For example, when discussing treatment-access forums or evolving site-based guidance, we may reference dedicated informational pages like the treatment-focused resource at ibogaine for extreme alcoholism when framing available experiential reports; such links are provided for context, not endorsement.
Our audience includes researchers, clinicians seeking clarity on study design, and members of the public who want evidence-first summaries. If you're seeking professional medical care, this site is not a substitute for consultation with licensed providers.
We begin sections with a diagram or flowchart, then expand into annotated notes. That diagram-first rhythm helps readers trace causal claims, measurement steps, and safety checkpoints before reading longer summaries.
Each diagram is paired with node cards and inline annotations that explain assumptions, measures, and uncertainty. Visual connectors clarify where evidence is strong and where it is suggestive.
To explore our editorial services and how we produce these resources, see our description of offerings on Services and editorial support.
Gentle Clearing 73 is an independent information resource and not a clinic, medical provider, or licensed treatment center. The content here is informational and not medical or legal advice. If you need clinical care or legal counsel, seek a licensed professional.
If you'd like to navigate back to our main hub for ongoing tracker content, use the site index available on the homepage at Gentle Clearing 73's main pages for quick orientation.